Rainbow Childrens Medicare Earnings Call Transcript: Key Takeaways
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
- Call
- Guides 18% growth
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
Q2 FY27 consolidated revenue ₹548 Cr (+23% YoY) and PAT ₹84 Cr (+11%). Post-IndAS EBITDA margin fell to 31.0% from 33.5%. Strategy is hub-and-spoke pediatric and maternity expansion across 26 hospitals.
Rainbow Children's Medicare delivered a strong Q1 FY27 with 33% revenue growth. Management is executing a massive 2,500-bed expansion plan aimed at doubling revenue within four years.
Rainbow is aggressively pivoting to a pan-India model, trading temporary margin pressure for a target to double revenue within four years through massive bed capacity expansion.
Rainbow Children’s Medicare Limited reports Q1 FY27 revenue of INR 4,700 Mn (+33% YoY) and EBITDA of INR 1,346.5 Mn (+30% YoY). Strategic focus on Hub and Spoke model expansion and JCI accreditation.
Rainbow Children’s Medicare reported Q4 FY26 revenue of ₹459.9cr (up 24%) and PAT of ₹78.2cr (up 38%). Strategy focuses on expanding pediatric specialty beds and building a 'hub-and-spoke' model across India.
Rainbow Childrens Medicare delivered its highest quarterly revenue and 20% YoY growth despite significant recent bed capacity additions. Management transitions are smooth with a focus on improving occupancies and clinical excellence.
Rainbow Children’s Medicare Limited reported strong Q4 FY26 performance with 24% YoY revenue growth and 26% EBITDA growth. Strategy focuses on deepening the 'Hub and Spoke' model across major Indian cities.